Syngenta Group is preparing a Hong Kong stock market listing that could raise as much as $10 billion, placing the company among the largest public offerings seen worldwide in recent years. The Swiss-based agrichemicals and seeds group, which is owned by China’s state-backed Sinochem, is in early talks with several international and Chinese banks about arranging the deal. The company may offer between 10% and 20% of its shares, although the final size and timing will depend on market conditions. If it reaches the top end of that range, the float would rank as the third-largest IPO globally in the past five years.
The company plans to use part of the proceeds to reduce debt, which stood at $24.8 billion at the end of 2024, while also funding research, development, and possible acquisitions. Syngenta also aims to lower Chinese ownership, a move that could help manage trade risks in key markets such as the United States. The listing plan follows improved financial performance, with profits rising 25% in the first nine months of 2025 despite slightly lower sales. The potential deal also supports Hong Kong’s renewed fundraising momentum, after the city led global IPO proceeds in 2025.
